Sie sind auf Seite 1von 54

9/28/2017 1

TON DUC THANG UNIVERSITY


FACULTY OF APPLIED SCIENCES
Department of Biotechnology

Chapter 2.
BIOPHARMACEUTICALS

Course number: 608003


Lecturer: Dinh-Chuong Pham, PhD

9/28/2017 608003 Chapter 2. Biopharmaceuticals 2


Chapter 2.
Biopharmaceuticals

2.1. Definition Classification


2.2. Recombinant proteins
2.3. Gene therapy

9/28/2017 608003 Chapter 2. Biopharmaceuticals 3


2.1. Definition - Classification

1. What do you think about the picture above?


2. What can you imagine when you hear the term biopharmaceuticals?

9/28/2017 608003 Chapter 2. Biopharmaceuticals 4


2.1. Definition - Classification
Biopharmaceuticals are protein-based and derived
from genetically altered bacteria, fungi, animal cells
(biotech drugs), from blood and blood plasma
products (biologics), from living cells or tissues.

9/28/2017 608003 Chapter 2. Biopharmaceuticals 5


2.1. Definition - Classification

4 major classes of biopharmaceuticals:

Extracted from Produced by


living cells recombinant DNA

Vaccine Gene therapy

9/28/2017 608003 Chapter 2. Biopharmaceuticals 6


2.1. Definition - Classification

Albumin
Vaccines

Stem cells

Gene therapy

Monoclonal antibodies
Hormones
9/28/2017 608003 Chapter 2. Biopharmaceuticals 7
2.1. Definition - Classification
Market growth

9/28/2017 608003 Chapter 2. Biopharmaceuticals 8


2.1. Definition - Classification
Global Therapeutic Protein Market

9/28/2017 608003 Chapter 2. Biopharmaceuticals 9


2.1. Definition - Classification
Biopharmaceutical companies

9/28/2017 608003 Chapter 2. Biopharmaceuticals 10


2.1. Definition - Classification

Top selling drugs

9/28/2017 608003 Chapter 2. Biopharmaceuticals 11


2.2. Recombinant proteins
Monoclonal antibody

Insulin

Interferone

9/28/2017 608003 Chapter 2. Biopharmaceuticals 12


2.2. Recombinant proteins

Which steps should we do to get recombinant proteins?

Choose host cells,


Transfect or transform vectors containing recombinant DNAs,
Select transfected or transformed cell clones,
Scale up,
Protein purification.

9/28/2017 608003 Chapter 2. Biopharmaceuticals 13


2.2. Recombinant proteins
Which steps should we do to get recombinant proteins?

9/28/2017 608003 Chapter 2. Biopharmaceuticals 14


2.2. Recombinant proteins
Host cells (most popular candidates)

Bacterial cells

9/28/2017 608003 Chapter 2. Biopharmaceuticals 15


2.2. Recombinant proteins
Host cells (most popular candidates)

Mammalian cells Advantages of mammalian cell expression system

Can express large proteins (> 50 kDa)


Correct glycosylation (PTM)
Proper folding
Solubility
Chinese hamster ovary cells
(CHO cells)

9/28/2017 608003 Chapter 2. Biopharmaceuticals 16


2.2. Recombinant proteins
Host cells (most popular candidates)

Plants
Advantages of plant expression system

High expression level


Less purification steps
Less contaminate the main product
Cheap
Tobacco

9/28/2017 608003 Chapter 2. Biopharmaceuticals 17


2.2. Recombinant proteins
Host cells (most popular candidates)

Yeasts
Advantages of yeast expression system

High expression level


Low cost
Ease of scaling
Proper protein folding
Pichia pastoris

9/28/2017 608003 Chapter 2. Biopharmaceuticals 18


2.2. Recombinant proteins

Host cells

9/28/2017 608003 Chapter 2. Biopharmaceuticals 19


2.2. Recombinant proteins
Recombinant DNA: DNA from different species can be isolated,
cut and spliced together to make new molecules.

Restriction enzymes
Ligase
Vectors (plasmid, phage)

9/28/2017 608003 Chapter 2. Biopharmaceuticals 20


2.2. Recombinant proteins
Restriction enzymes
Known as Restriction Endonuclease,
Cut DNA at specific Recognition Nucleotide Sequences
(Restriction Sites):
4, 6, or 8 in length, 4n base pairs appear by chance
Palindromic (OTTO, HANNAH)

9/28/2017 608003 Chapter 2. Biopharmaceuticals 21


2.2. Recombinant proteins
Ligase

9/28/2017 608003 Chapter 2. Biopharmaceuticals 22


2.2. Recombinant proteins
Bacterial expression plasmid

9/28/2017 608003 Chapter 2. Biopharmaceuticals 23


2.2. Recombinant proteins
Bacterial expression plasmid

9/28/2017 608003 Chapter 2. Biopharmaceuticals 24


2.2. Recombinant proteins
Mammalian expression plasmid

9/28/2017 608003 Chapter 2. Biopharmaceuticals 25


2.2. Recombinant proteins
Mammalian expression plasmid

9/28/2017 608003 Chapter 2. Biopharmaceuticals 26


2.2. Recombinant proteins
Transformation Heat shock

1 hour 1 minute 3 minutes

37oC, 18 hours

9/28/2017 608003 Chapter 2. Biopharmaceuticals 27


2.2. Recombinant proteins
Transformation Electroporation

9/28/2017 608003 Chapter 2. Biopharmaceuticals 28


2.2. Recombinant proteins
Transfection - Lipofection

9/28/2017 608003 Chapter 2. Biopharmaceuticals 29


2.2. Recombinant proteins
Selected cell clones of interest

Grow cell dilutions in presence of selector: MTX (methotrexate) or


MSX (methionine sulfoximine),
Choose clones that survive selection
Screen clones
High and stable expression of intact recombinant protein
Fast growth
But growth and expression often inversely related

9/28/2017 608003 Chapter 2. Biopharmaceuticals 30


2.2. Recombinant proteins
Protein purification strategy

9/28/2017 608003 Chapter 2. Biopharmaceuticals 31


2.2. Recombinant proteins
Affinity tags

9/28/2017 608003 Chapter 2. Biopharmaceuticals 32


2.2. Recombinant proteins
Affinity tags

9/28/2017 608003 Chapter 2. Biopharmaceuticals 33


2.2. Recombinant proteins

Watch and Listen the Video.


Your task is to understand it to answer the questions below:

1. What cell line do they use for making products?


2. Why does he wear the special clothes before enterring the
facilities?
3. Do cells secrete protein of interest inside or outside their
bodies?
4. What step should they do to get protein of interest from the
complex mixture?

9/28/2017 608003 Chapter 2. Biopharmaceuticals 34


2.2. Recombinant proteins

Watch and Listen the Video.


Your task is to understand it to answer the questions
below:

1. What is HER2?
2. Mode of action of HERCEPTIN?

9/28/2017 608003 Chapter 2. Biopharmaceuticals 35


2.3. Gene therapy

9/28/2017 608003 Chapter 2. Biopharmaceuticals 36


2.3. Gene therapy

Technique that uses genes to treat or prevent diseases

Therapeutic genes or Transgene


9/28/2017 608003 Chapter 2. Biopharmaceuticals 37
2.3. Gene therapy

9/28/2017 608003 Chapter 2. Biopharmaceuticals 38


2.3. Gene therapy

Germ line gene therapy

Germ cells (sperms, eggs) are modified by the introduction of


functional genes into genomes.

The change would be heritable and passed on later generation.

9/28/2017 608003 Chapter 2. Biopharmaceuticals 39


2.3. Gene therapy
Germ line gene therapy

9/28/2017 608003 Chapter 2. Biopharmaceuticals 40


2.3. Gene therapy
Germ line gene therapy

9/28/2017 608003 Chapter 2. Biopharmaceuticals 41


2.3. Gene therapy

Somatic gene therapy

Therapeutic genes are transferred into the somatic cells of


a patient .

Any modification and effect will be restricted to the patient


only, and will not be inherited.

9/28/2017 608003 Chapter 2. Biopharmaceuticals 42


2.3. Gene therapy
Somatic gene therapy

Ex vivo In vivo
Cells are modified Genes are changed in
outside the body and cells when the cells are
then transplanted back still in the body
in again

Called in vivo because


Called ex vivo because
the gene is transferred
the cells are treated
to cells inside the
outside the body
patients body

9/28/2017 608003 Chapter 2. Biopharmaceuticals 43


2.3. Gene therapy
Somatic gene therapy

9/28/2017 608003 Chapter 2. Biopharmaceuticals 44


2.3. Gene therapy
Vectors in gene therapy

To transfer the desired gene into a


target cell, a carrier is required.
Such vehicles of gene delivery
are known as vectors.

2 main classes:
Viral vectors
Non-viral vectors

9/28/2017 608003 Chapter 2. Biopharmaceuticals 45


2.3. Gene therapy
Viral vector - Retrovirus

The recombinant retroviruses have the ability to integrate into the host
genome in a stable fashion.

Can carry a DNA of


size less than 3.4 kb

Replication defective
virus particles

Target cell - dividing


9/28/2017 608003 Chapter 2. Biopharmaceuticals 46
2.3. Gene therapy
Viral vector - Adenovirus

Adeno virus with a DNA


genome good vectors.

Target- non dividing human


cell.

Eg. Common cold adenovirus.

9/28/2017 608003 Chapter 2. Biopharmaceuticals 47


2.3. Gene therapy
Non-viral vector Naked DNA

Direct introduction of pure DNA


construct into target tissue .

Efficiency of DNA uptake by cells and


expression rather low.

Consequently, large quantities of DNA


have to be injected periodically.

9/28/2017 608003 Chapter 2. Biopharmaceuticals 48


2.3. Gene therapy
Non-viral vector Particle based

1 and 100 nanometers in size.


Binding to cell membranes, cytoplasmic or nuclear receptor sites.

9/28/2017 608003 Chapter 2. Biopharmaceuticals 49


2.3. Gene therapy
Non-viral vector Chemical based

Lipid DNA complexes; DNA


construct surrounded by artificial
lipid layer.

Liposome gets degraded by


lysosomes.

9/28/2017 608003 Chapter 2. Biopharmaceuticals 50


2.3. Gene therapy
Applications

Gascon RA. et al.2013

9/28/2017 608003 Chapter 2. Biopharmaceuticals 51


2.3. Gene therapy
Antiviral strategy - HIV

Proudfoot A., (2013)


9/28/2017 608003 Chapter 2. Biopharmaceuticals 52
2.3. Gene therapy

9/28/2017 608003 Chapter 2. Biopharmaceuticals 53


9/28/2017 608003 Chapter 2. Biopharmaceuticals 54

Das könnte Ihnen auch gefallen